Patents by Inventor Kimberly E. VANOVER

Kimberly E. VANOVER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USES
    Publication number: 20250090536
    Abstract: The disclosure provides methods, treatments and materials for treating diseases or disorders associated with the dopamine D1 receptor intracellular pathway. In particular, the present disclosure provides for methods of treating such diseases and disorders in combination with a dopamine replacement therapy.
    Type: Application
    Filed: December 3, 2024
    Publication date: March 20, 2025
    Inventors: Robert E. DAVIS, Kimberly E. VANOVER
  • Uses
    Patent number: 12194042
    Abstract: The disclosure provides methods, treatments and materials for treating diseases or disorders associated with the dopamine D1 receptor intracellular pathway. In particular, the present disclosure provides for methods of treating such diseases and disorders in combination with a dopamine replacement therapy.
    Type: Grant
    Filed: October 21, 2019
    Date of Patent: January 14, 2025
    Assignee: INTRA-CELLULAR THERAPIES, INC.
    Inventors: Robert E. Davis, Kimberly E. Vanover
  • NOVEL USES
    Publication number: 20210379072
    Abstract: The disclosure provides methods, treatments and materials for treating diseases or disorders associated with the dopamine D1 receptor intracellular pathway. In particular, the present disclosure provides for methods of treating such diseases and disorders in combination with a dopamine replacement therapy.
    Type: Application
    Filed: October 21, 2019
    Publication date: December 9, 2021
    Inventors: Robert E. DAVIS, Kimberly E. VANOVER